Abstracts tagged "Fever"

Abstract Number: 052 • 2023 Pediatric Rheumatology Symposium
Extreme Periodic Fever, Aphthous Stomatitis, Pharyngitis, Adenitis (PFAPA): A Discrete Group of Patients
Yoel Levinsky¹, Rotem Tal², Liora Harel², Shoval Shoham³, Sabreen Abu Ahmad⁴, Yonatan Butbul Aviel⁵, Gil Amarilyo² and Mor Broide³, ¹Schneider Children's Medical Center of Israel, Petach Tikva, Israel, ²Pediatric rheumatology clinic, Schneider children's medical center of Israel, Petach Tikva, Israel, ³Schneider Children's Medical Center of Israel, Petach Tikva, Israel, ⁴Ruth Rappaport Children's Hospital, Rambam Health Care, Haifa, Israel, ⁵Rambam Medical center, Haifa, Israel
Background/Purpose: Periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome is the most common periodic fever syndrome in children; by definition, episodes occur every…
Abstract Number: 0252 • ACR Convergence 2021
Role of Clinical and Laboratory Parameters in Differentiating Infection from Disease Flare in Febrile Patients of Systemic Juvenile Idiopathic Arthritis
Rajesh Kanumuri¹, Suma Balan², Vishal Marwaha², Sajitha Krishnan² and Pranav Chickermane², ¹Amrita Institute of Medical Sciences, Guntur, India, ²Amrita Institute of Medical Sciences, Kochi, India
Background/Purpose: Fever is the most common presentation of systemic juvenile idiopathic arthritis (SJIA) and it is difficult to predict whether the fever is due to…
Abstract Number: 069 • 2020 Pediatric Rheumatology Symposium
Rheumatic Fever in a Tertiary Medical Center – 25 Years of Follow Up
Liora Harel ¹, Gil Amarilyo ² and mohammad hammad saied³, ¹Schneider Hospital, Tel Aviv University, Petah-Tiqva, Israel, ²Schneider Hospital, Tel Aviv University, Kibbutz Magal, Israel, ³Schneider Medical Center, Kaboul village 24963, Israel
Background/Purpose: Rheumatic Fever (RF) occurs after a pharyngeal infection caused by group A-B-hemolytic streptococci.Its principal clinical significance is causing carditis at the acute phase of…
Abstract Number: 1431 • 2018 ACR/ARHP Annual Meeting
Kikuchi-Fujimoto Disease: A Retrospective Analysis of 23 Pediatric Cases from a US Center
Ekemini Ogbu^1,2, Shanmuganathan Chandrakasan^1,2, Sunita Park^1,2 and Sampath Prahalad^1,2, ¹Pediatrics, Emory University, Atlanta, GA, ²Children's Healthcare of Atlanta, Atlanta, GA
Background/Purpose: Kikuchi-Fujimoto Disease (KFD) is often described as a benign self-limited disease. However, there is a risk of recurrence. It is most common in adult…
Abstract Number: 377 • 2017 ACR/ARHP Annual Meeting
Novel Insights into Periodic Fever Syndromes
Tiffany Hoang¹, Shreya Shrestha¹ and Daniel Albert², ¹Dartmouth Medical School, Lebanon, NH, ²Medicine/Rheumatology, Dartmouth-Hitchcock Med Ctr, Lebanon, NH
Background/Purpose: The Periodic Fever Syndromes (PFS) are a rapidly expanding group of disorders primarily of the innate immune system that often affect the inflammasome. In…
Abstract Number: 81 • 2017 Pediatric Rheumatology Symposium
Preliminary Consensus Treatment Plans for Periodic Fever, Aphthous Stomatitis, Pharyngitis and Adenitis: The Foundation for Capturing Treatment Responses in PFAPA from the CARRA PFAPA Subcommittee
Gil Amarilyo¹, Deborah Rothman², Kalpana Manthiram³, Suzanne Li⁴, Liora Harel⁵, Kathryn Edwards⁶, Gary Marshall⁷, Simona Nativ⁸, Kathleen Haines⁹, Geraldina Lionetti¹⁰, Julie Cherian¹¹, Yongdong Zhao¹², Patricia DeLaMora¹³, Grant Syverson¹⁴, Ian Michelow¹⁵, Yuriy Stepanovskiy¹⁶, Akaluck Thatayatikom¹⁷, Cagri Yildirim-Toruner¹⁸, Shoghik Akoghlanian¹⁹, Lori Tucker²⁰, Katalin Koranyi¹⁹, Hemaltha Srinivasalu²¹, Fatma Dedeoglu²² and Sivia Lapidus⁸, ¹Schneider Children's Medical Center of Israel, Sackler School of Medicine, Tel Aviv University, Petach Tikva, Israel, ²Albany Medical Center, Albany, NY, ³National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, ⁴Pediatrics, Joseph M Sanzari Children’s Hospital, Hackensack Meridian Health, Hackensack, NJ, ⁵Schneider Children's Medical Center of Israel, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel, ⁶Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, TN, ⁷Norton Children's Hospital, University of Louisville, Louisville, KY, ⁸Pediatric Rheumatology, Goryeb Children's Hospital, Morristown, NJ, ⁹Joseph M Sanzari Children’s Hospital, Hackensack Meridian Health, Hackensack, NJ, ¹⁰Pediatric Rheumatology, UCSF Benioff Children's Hospital Oakland, Oakland, CA, ¹¹Department of Pediatrics, Stony Brook University Hospital, Stony Brook, NY, ¹²Seattle Children's Hospital, Department of Pediatric Rheumatology, University of Washington, Seattle, WA, ¹³Weill Cornell Medical College, New York, NY, ¹⁴Pediatric Rheumatology, Medical College of Wisconsin, Wauwatosa, WI, ¹⁵Center for International Health Research, Alpert Medical School of Brown University, Providence, RI, ¹⁶Shupyk National Academy of Postgraduate Education, Kyiv, Ukraine, ¹⁷UF Health Shands Hospital, Gainesville, FL, ¹⁸Rheumatology, Nationwide Children's Hospital, Columbus, OH, ¹⁹Nationwide Children's Hospital, Columbus, OH, ²⁰Pediatric Rheum/Rm K4-120, BC Childrens Hospital, Vancouver, BC, Canada, ²¹Children's National Medical Center, Washington, DC, ²²Division of Immunology, Rheumatology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA
Background/Purpose: PFAPA is the most common recurrent fever condition in children. A recent survey showed heterogeneity in physicians’ management strategies. In order to evaluate the…
Abstract Number: 78 • 2017 Pediatric Rheumatology Symposium
Predictors of Outcome Following Tonsillectomy in Periodic Fever, Aphthous Stomatitis Pharyngitis, and Cervical Adenitis (PFAPA) Syndrome
Kalpana Manthiram¹, Daniel L. Kastner^2,3 and Kathryn Edwards⁴, ¹National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, ²Inflammatory Disease Section, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, ³Inflammatory Disease Section, NHGRI/NIH, Bethesda, MD, ⁴Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, TN
Background/Purpose: Tonsillectomy is considered curative in a majority of patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome. Predictors of outcome following…
Abstract Number: 83 • 2017 Pediatric Rheumatology Symposium
Feverprints: A Crowdsourcing Study of Temperature in Health and Disease
Jonathan S. Hausmann^1,2, Nitin Gujral³, Soleh Al Ayubi³, Jared B. Hawkins³, John S. Brownstein³ and Fatma Dedeoglu², ¹Rheumatology, Beth Israel Deaconess Medical Center, Boston, MA, ²Rheumatology, Boston Children's Hospital, Boston, MA, ³Innovation & Digital Health Accelerator, Boston Children's Hospital, Boston, MA
Background/Purpose: Autoinflammatory diseases (AIDs) are a rare group of illnesses characterized by unprovoked episodes of fever and systemic inflammation. An understanding of their pathophysiology has…
Abstract Number: 2383 • 2016 ACR/ARHP Annual Meeting
Analysis of the Use of Anticoagulants and Antiplatelet Agents in Strokes Caused By the Deficiency of Adenosine Deaminase 2
Patrycja Hoffmann¹, Amanda K. Ombrello², Deborah L. Stone¹, Karyl Barron³, Gineth Pinto-Patarroyo¹, Anne Jones¹, Tina Romeo⁴, Dean Follmann⁵, Camilo Toro⁶, Ariane Soldatos⁷, Qing Zhou⁸, Ivona Aksentijevich¹ and Daniel L. Kastner¹, ¹Inflammatory Disease Section, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, ²Inflammatory Diseases Section, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, ³National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, ⁴National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, ⁵NIAID, Bethesda, MD, ⁶NIH Undiagnosed Diseases Program, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, ⁷National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, ⁸Inflammatory Disease Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD
Background/Purpose: Deficiency of adenosine deaminase 2 (DADA2) is a recessive genetic condition in which children develop recurrent strokes, intermittent fevers, elevated acute-phase reactants, livedoid rash,…
Abstract Number: 940 • 2015 ACR/ARHP Annual Meeting
NOD2-Associated Autoinflammatory Disease: Therapy and Outcomes
Qingping Yao¹ and Bo Shen², ¹Cleveland Clinic, Cleveland, OH, ²Gastroenterology, Cleveland Clinic, Cleveland, OH
Background/Purpose: NOD2-associated autoinflammatory disease, now redesignated as Yao Syndrome(YS) is a newly described and increasingly recognized entity. It is characterized by periodic fever, dermatitis, polyarthritis, sicca-like…
Abstract Number: 1400 • 2015 ACR/ARHP Annual Meeting
Hyperferritinemia and Fever in Adults
Kensuke Nakanishi and Mitsuyo Kinjo, Rheumatology, Okinawa Chubu Hospital, Uruma, Japan
Background/Purpose: Clinical associations of hyperferritinemia include: hepatocellular injury, hemophagocytic lymphohistiocytosis (HLH), hematologic malignancy, adult-onset Still’s disease (AOSD), and iron overload. Fever of undetermined origin (FUO)…
Abstract Number: 2029 • 2015 ACR/ARHP Annual Meeting
Fever of Unknown Origin (FUO) and Inflammation of Unknown Origin (IUO): Is 18f-FDG-PET/CT a Useful First Line Diagnostic Strategy?
Verena Schönau¹, Kristin Vogel², Matthias Englbrecht³, Bernhard Manger³, Daniela Schmidt⁴, Torsten Kuwert⁴ and Georg Schett², ¹Department of Rheumatology and Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, ²Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, ³Department of Internal Medicine 3, Rheumatology & Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, ⁴Clinic of Nuclear Medicine, University of Erlangen-Nuremberg, Erlangen, Germany
Background/Purpose: FUO and IUO are rare but diagnostically challenging clinical problems. Because of the abundance of differential diagnoses, a generally accepted diagnostic guideline has not…
Abstract Number: 3092 • 2015 ACR/ARHP Annual Meeting
Deficiency of Adenosine Deaminase Type II – Expanding the Clinical Spectrum
Karyl Barron¹, Amanda Ombrello², Deborah Stone², Patrycja Hoffmann², Ivona Aksentijevich^2,3, Qing Zhou², Anne Jones² and Daniel L. Kastner⁴, ¹NIAID/NIH, Bethesda, MD, ²NHGRI/NIH, Bethesda, MD, ³Inflammatory Disease Section, National Human Genome Research Institute, Bethesda, MD, ⁴Inflammatory Disease Section, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD
Background/Purpose: The deficiency of adenosine deaminase II (DADA2), first described in 2014, is an autosomal recessive disease caused by mutations in CECR1and is characterized by…
Abstract Number: 1234 • 2014 ACR/ARHP Annual Meeting
Periodic Fever Syndromes in an Academic Medical Center
Mark Cervinski¹ and Daniel Albert², ¹Pathology, Dartmouth Hitchcock Medical Center, Lebanon, NH, ²Medicine, The Dartmouth Institute for Health Policy and Clinical Practice, lebanon, NH
Background/Purpose: Most published clinical data on this rapidly evolving group of diseases are from highly specialized centers and do not reflect what is commonly seen…
Abstract Number: 1211 • 2013 ACR/ARHP Annual Meeting
Adult Autoinflammatory Phenotypes Associated With Heterozygous MEFV Mutations: A Continuum of Familial Mediterranean Fever?
Qingping Yao, Rheumatic and Immunologic Dis, Cleveland Clinic, Cleveland, OH
Background/Purpose: Familial Mediterranean fever (FMF) is traditionally regarded as an autosomal recessive disease characterized by periodic fever, serositis, erysipelas-like erythema and good response to colchicine. The…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].